Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN TYPE A Cause Dysphonia? 191 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 191 reports of Dysphonia have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 5.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.

191
Reports of Dysphonia with BOTULINUM TOXIN TYPE A
5.1%
of all BOTULINUM TOXIN TYPE A reports
0
Deaths
17
Hospitalizations

How Dangerous Is Dysphonia From BOTULINUM TOXIN TYPE A?

Of the 191 reports, 17 (8.9%) required hospitalization, and 1 (0.5%) were considered life-threatening.

Is Dysphonia Listed in the Official Label?

Yes, Dysphonia is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.

What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?

Off label use (1,785) Drug ineffective (1,175) Drug intolerance (1,004) Product use in unapproved indication (950) Headache (797) Migraine (775) Maternal exposure during pregnancy (716) Pain (714) Hypoaesthesia (703) Nausea (665)

What Other Drugs Cause Dysphonia?

FLUTICASONE\SALMETEROL (1,729) CABOZANTINIB S-MALATE (1,229) ADALIMUMAB (1,216) BUDESONIDE\FORMOTEROL (1,204) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (1,143) ALBUTEROL (1,114) LENVATINIB (1,021) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (943) LENALIDOMIDE (931) AMIKACIN (914)

Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Dysphonia Risk?

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE BOTULINUM TOXIN TYPE A vs BRENTUXIMAB BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN TYPE A vs BREO ELLIPTA BOTULINUM TOXIN TYPE A vs BREXANOLONE

Related Pages

BOTULINUM TOXIN TYPE A Full Profile All Dysphonia Reports All Drugs Causing Dysphonia BOTULINUM TOXIN TYPE A Demographics